Regeneron and Sanofi Get Favorable Ruling Against AmgenRegeneron Pharmaceuticals(REGN) and partner Sanofi, Inc. (SNY) receives a favorable ruling from the Court of Appeals for the Federal Circuit relating to Praluent.


Read More At Article Source | Article Attribution